How to Identify and Claim Artery Network Airdropsby John Darbie 24.06.2024Learn how to identify and claim Artery Network airdrops with our detailed guide on finding, securing, and managing your tokens ...
50 Cent’s Account Hacked to Promote Memecoins – Stay Vigilantby John Darbie 24.06.2024Rapper 50 Cent's Twitter and website hacked to promote a memecoin, $GUNIT. Clarifies no link to the coin. Warns crypto ...
Ripple CTO Reveals Bitcoin Strategy and XRP Holdingsby John Darbie 24.06.2024Ripple CTO David Schwartz clarifies crypto strategies and Bitcoin insights, discussing early investors' behavior and his own crypto holdings and ...
Bitcoin Analyst Defies Bears, Predicts $100K Target for BTCby John Darbie 24.06.2024Bitcoin price predictions suggest bullish future: Analyst forecasts $100K in 30 days, while Bernstein Research targets $200K by 2025. Read ...
Dogecoin Eyes $0.15 Rally Despite Twitter Payment Snubby John Darbie 23.06.2024"Dogecoin miners accumulate $13.7M in DOGE, bolstering price above $0.12. Could DOGE rally to $0.15 despite Elon Musk's Twitter exclusion?"
50 Cent Claims Hacker Stole $300M via X Account in 30 Minutesby John Darbie 23.06.202450 Cent claims hacker stole $300M in 30 mins using his hacked social media to promote a fake crypto, $GUNIT. ...
Musk’s X Payments Plan Excludes DOGE, Dampering Hopesby John Darbie 22.06.2024"Dogecoin dreams fade as Elon Musk's X platform reveals no crypto plans, denting hopes of DOGE integration and impacting its ...
Analysts Baffled as Bitcoin Hits ATH Amid User Declineby John Darbie 20.06.2024"IntoTheBlock reveals puzzling Bitcoin trend: high network activity but low new user adoption sees BTC price stagnate despite ATH."
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...